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Background
HIV-infected women are at increased risk of cervical HPV
infection and neoplasia. We investigated whether HIV-
infected women are also at high risk for HPV infection of
the anal canal and anal dysplasia.
Methods
We performed a pilot, prospective, observational study on
100 HIV-infected women presenting for routine HIV care.
Subjects were interviewed and underwent cervical and
anal testing with cytology and HPV with Hybrid Capture
2 assay (Digene Corporation, Gaithersburg, MD). High
resolution anoscopy (HRA) or colposcopy were per-
formed if indicated and subjects with high grade dysplasia
were referred for treatment. Secondary analyses were per-
formed to assess for associated risk factors for abnormal
cervical or anal cytology or HPV infection such as CD4 T-
cell count using SPSS for Windows, version 15.0.
Results
The average age of the subjects was 41 years and 78 per-
cent of the women were currently on highly active antiret-
roviral therapy.
The prevalence of high-risk HPV infection in the cervix
was 24 percent and cervical cytological abnormality was
21.6 percent. Of the 24 patients with cervical HPV infec-
tion, 15 (62.5%) had cervical cytological abnormalities.
(Fisher Exact Test, p = 0.0001).
The prevalence of high risk HPV infection in the anus was
16 percent and anal cytological abnormality was 17 per-
cent. Of the 16 patients with anal HPV infection, 10
(62.5%) had anal cytological abnormalities (Fisher Exact
Test, p = 0.0001).
Eleven of 24 women (46%) who had high risk HPV in the
cervix also had high risk HPV detected in the anal canal
(Fisher Exact Test, p = 0.0001). Eight of 21 women (38
percent) who had abnormal cervical cytology also had
abnormal anal cytology (Fisher Exact Test, p = 0.0001).
Subjects with anal HPV infection (mean CD4 count 349
cells/μl) had significantly lower mean CD4 counts com-
pared to subjects without anal HPV infection (mean CD4,
555 cells/μl) (t test, p = 0.007). Subjects with abnormal
anal cytology (mean CD4 393 cells/μl) had significantly
lower mean CD4 counts compared with subjects with
normal anal cytology (mean CD4, 550 cells/μl) (t-test, p
= 0.007).
Similarly, subjects with cervical HPV infection were signif-
icantly more likely to have lower mean CD4 count (394
cells/μl) compared to those without cervical HPV infec-
tion (564 cells/μl) (t-test, p = .01). Subjects with abnor-
mal cervical cytology also had lower mean CD4 count
(372 cells/μl) compared to women with normal cervical
cytology (CD4, 549 cells/μl) (t-test, p = .004).
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Of the 16 patients who underwent colposcopy, eight had
low-grade and five had high-grade cervical or vaginal dys-
plasia. Of the 11 women who underwent HRA, six had
low-grade and three had high-grade anal dysplasia.
Conclusion
Anal and cervical HPV infections are common in HIV-
infected women. HIV-infected women have high rates of
anal and cervical dysplasia. These findings provide further
data for developing anal cytology screening recommenda-
tions for this patient population.Page 2 of 2
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